← Open Payments lookup

RAFAEL GUERRERO: Open Payments

NPI 1386600138 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,239 in 174 payments from 20 companies in 2025. Trend: 2023 $3,136 · 2024 $3,157 · 2025 $4,239

Food & beverage: $4,174Education: $65
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$764
Otsuka America Pharmaceutical, Inc.18$608
Neurocrine BioSciences, Inc.12$366
ABBVIE INC.23$333
Alkermes, Inc.10$251
Axsome Therapeutics, Inc.6$226
HARMONY BIOSCIENCES LLC5$213
Lundbeck LLC9$205
E.R. Squibb & Sons, L.L.C.7$196
Vanda Pharmaceuticals Inc.9$193

Products named: CAPLYTA, REXULTI, INGREZZA, VRAYLAR, ARISTADA, COBENFY, FANAPT, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.